Stocks Under $10: Midwest Community Banks

Richard Suttmeier |

Stocks Under $10: Midwest Community BanksAt www.ValuEngine.com we show that the Finance sector is 13.3% overvalued. The Banks Midwest industry is 4.5% overvalued. All five stocks in today’s table have complete ValuEngine data and have enough price data to have most value levels, risky levels and pivots.

BUSE – was a $23 stock in February 2007 and has been below $10 since the week of April 4, 2009.
BYLK – was a $16 stock in January 2007, then traded as low as $1.55 in February 2009 and tested $10 on March 1, 2013.
HBAN – was a $24 stock in February 2007 and has been below $10 since the week of November 15, 2008.
LNBB – has been below $10 since the week of October 11, 2008.
OSBC – was a $30 stock in October 2007 and has been below $10 since the week of January 24, 2009.

Reading the Table

OV/UN Valued – The stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine. The most undervalued stock in today’s table is OSBC 56.8%. The most overvalued stock is LNBB by 19.7%.

VE Rating – A “1-Engine” rating is a Strong Sell, a “2-Engine” rating is a Sell, a “3-Engine” rating is a Hold, a “4-Engine” rating is a Buy and a “5-Engine” rating is a Strong Buy. Two are rated Buy (BYLK & OSBC) and three are rated Hold.

Last 12-Month Return (%) – Stocks with a Red number declined by that percentage over the last twelve months. Stocks with a Black number increased by that percentage over the past twelve months! The biggest gainer over the last 12 months is OSBC up by 91.1%. The only loser is BUSE by 5.5%.

Forecast 1-Year Return – Stocks with a Red number are projected to decline by that percentage over the next twelve months. Stocks with a Black number in the Table are projected to move higher by that percentage over the next twelve months. The range of expectations is between a loss of 0.6% (LNBB) and a gain of 5.8% (BYLK).

P/E Ratios – The 12 month trailing P/E ratios – HBAN has a single-digit P/E ratio.

Value Level: is the price at which to enter a GTC Limit Order to buy on weakness. The letters mean; W-Weekly, M-Monthly, Q-Quarterly, S-Semiannual and A- Annual.

Pivot: A level between a value level and risky level that acts as a magnet during the time frame noted.

Risky Level: is the price at which to enter a GTC Limit Order to sell on strength.

Where to Buy and Where to Sell

A “Value Level” is a price at which buyers should add to positions on market price weakness. A “Risky Level” is a price at which sellers should reduce holdings on market price gains. A "Pivot" is a support or resistance (Value Level or Risky Level) that was violated in its time horizon, acting as a magnet during the remainder of that time horizon. These levels are calculated in weekly (W), monthly (M), quarterly (Q), semiannual (S) and annual (A) time horizons, based on the past nine closes in each time horizon. My theory is that the closes over a nine-year period are the summation of all bullish and bearish events for that market or specific stock. These levels are the most important element of my Buy and Trade Strategy.

Buy and Trade Guidelines

Investors should consider entering good until cancelled (GTC) orders to buy weakness to a value level, or to sell strength to a risky level.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BYLK Baylake Corp. (WI) n/a n/a n/a 0
BUSE First Busey Corporation 29.71 0.44 1.50 105,219
HBAN Huntington Bancshares Incorporated 13.46 0.25 1.89 23,825,002
XOOM Xoom Corporation n/a n/a n/a 0
OSBC Old Second Bancorp Inc. 9.80 0.35 3.70 86,669

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…